GMR Solutions Inc. Announces Pricing of its Initial Public Offering
HealthcareTexasOther
GMR Solutions
May 13, 2026
Gilead to Acquire Ouro Medicines for Autoimmune
Announced
HealthcareOther
Deal Overview
Gilead Sciences agreed to acquire Ouro Medicines to expand its autoimmune therapy portfolio. The article frames the transaction as a strategic expansion within Gilead’s autoimmune and immunology focus.
Key Details
- Transaction
- Gilead Sciences acquires Ouro Medicines
- Deal Size
- Over $100M
Source
Read full article on news.google.comvia GN - entered into definitive agreement · March 24, 2026
Related Deals
Artera gets FDA clearance for AI breast cancer risk prediction tool
Healthcare
Artera
May 12, 2026
Ophthalmology MSO receives private equity investment
HealthcareDelawarePlatform
Brightstar Capital Partners→Simon Eye
May 12, 2026
PE-backed Chartis subsidiary HealthScape Advisors acquires indie pharmacy PayerAlly
HealthcareAdd-on
HealthScape Advisors→PayerAlly
May 12, 2026
MACROGENICS INC — SEC 8-K Filing
HealthcareMarylandDivestiture
Bora Biologics USA→MacroGenics
May 12, 2026